In children with Autism spectrum disorder (ASD), Improvement of behaviour, communication and learning skills, were observed after a 90-day clinical study after consumption of a novel beta glucan (Nichi-Glow) compared to those who didn’t and this outcome was published in BMJ Neurology Open, a publication